Iveda Solutions, Inc. 10-K

ITEM 5 – MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES Market Information Our common stock is listed on The Nasdaq Capital Market under the symbol “IVDA” since April 1, 2022. Set forth in the table below is information with respect to the high and low bid quotations of our common stock for the periods indicated as reported by NASDAQ and the OTC Markets. The quotations represent inter-dealer prices without retail mark-ups, mark-downs, or commissions and may not necessarily represent actual transactions. See the High and Low Bid data below: Fiscal Year 2024 High Bid Low Bid First Quarter $ 2.91 $ 0.57 Second Quarter $ 1.90 $ 1.04 Third Quarter $ 1.15 $ 0.74 Fourth Quarter $ 8.05 $ 1.27 Fiscal Year 2023 High Bid Low Bid First Quarter $ 10.16 $ 4.40 Second Quarter $ 7.60 $ 3.60 Third Quarter $ 4,56 $ 1.51 Fourth Quarter $ 7.60 $ 4.56 As of December 31, 2024, we had 2,808,071 shares of our Common Stock, par value $0.00001, issued and outstanding. There were approximately 25,000 beneficial owners of our Common Stock. There is limited trading activity in our securities, and there can be no assurance that a regular trading market for our common stock will be sustained. Security Holders As of December 31, 2024, we had 2,808,071 shares of our common stock outstanding held by 96 shareholders of record, 0 shares of our Series A Preferred Stock outstanding and 0 shares of our series B Preferred Stock. Dividend Policy We have never paid a cash dividend on our common stock. We currently intend to retain all earnings, if any, to finance the growth and development of our business. We do not anticipate paying any cash dividends in the foreseeable future. Equity Compensation Plans For equity compensation plans information refer to Item 12 of Part III of this Annual Report on Form 10-K. 26 Recent Sales of Unregistered Securities Set forth below are the sales of all securities by the Company within the past three years which were not registered under the Securities Act. The Company believes that each of such issuances was exempt from registration under the Securities Act in reliance on Section 4(a)(2) of the Securities Act and/or Regulation S under the Securities Act. Between January 1, 2022 and December 31, 2022 the Company issued 8,215 shares of common stock to warrant holders upon exercise of $23,000 in proceeds. Between January 1, 2023 and December 31, 2023 the Company issued 19,656 shares of restricted common stock for services valued at $138,547. On September 6, 2024, the Company agreed to sell and issue to investors unregistered Series A Common Stock Purchase Warrants (the “Series A Warrants”) to purchase up to 5,000,000 shares of Common Stock and unregistered Series B Common Stock Purchase Warrants (the “Series B Warrants,” and collectively with the Series A Warrants, the “Common Warrants”) to purchase up to 5,000,000 shares of Common Stock. The Common Warrants will be exercisable on the effective date the Company obtains stockholder approval (the “Stockholder Approval”) of the issuance of the shares underlying the exercise of the Common Warrants (the “Common Warrant Shares”), at an exercise price of $0.43 per share. The Series A Warrants will expire five years following the Stockholder Approval and the Series B Warrants will expire 18 months following the Stockholder Approval. Between January 1, 2024 and December 31, 2024 the Company issued 12,500 shares of restricted common stock for services valued at $90,000. All of the securities referred to, above, were issued without registration under the Securities Act of 1933, as amended (the “Securities Act”) in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act as provided in Rule 506(b) of Regulation D promulgated thereunder. ITEM 6 – SELECTED FINANCIAL DATA Not applicable.